Beacon ADC Database Summary
- Unrivalled comprehensive & accurate preclinical & clinical ADC drug, trial and commercial data
- Access to 3,300+ Drugs, 3,800+ Trials, 2,000+ Companies, and 2,000+ Deals in the ADC space.
- Market leading ontologies, enabling precise navigation of specific ADC technologies
- Manually curated by ADC scientists, with data updated daily
- Your one-stop shop for ADC intelligence data

Why Beacon ADC Database?
How Beacon ADC Database Can Help You?
Give your ADC molecular design the best chance of success for a given target, by gaining a comprehensive overview into successful & failed strategies for a given payload, linker & antibody technology. Learn from other ADC programs that have gone after novel targets and how they progressed these assets.
Benchmark your preclinical ADC research with confidence by accessing preclinical ADC data captured and summarised from conference abstracts, posters, investor decks and more, all with links to this source material.
All preclinical literature is tagged to the type of data being disclosed into the following categories, with the ability to filter results to a specific type of preclinical data:
- In-Vitro
- Efficacy
- Toxicity
- PK/PD
Track clinical ADC developments through to approvals with a market leading curation approach, segmenting clinical readouts into drug dosing, patient data, toxicity & results, with 100s of conferences curated.
Use Beacon’s unique combination search functionality to determine your asset’s potential in combination with checkpoint inhibitors, DDR drugs, chemotherapies and more.
Utilise alert functionality to be notified immediately on release of new ADCs and new ADC data for your targets, indications and payload classes of interest.
Take advantage of Beacon’s ontologies that are constantly evolving to respond to industry trends, recently added searchable categories include:
- Bispecific ADC
- Dual-Payload ADC
- Degrader-ADC (DAC)
Confidently communicate your position in the increasingly crowded ADC market to investors. Show you’ve done your homework on competitors and have thoroughly benchmarked your readouts.
Utilise Beacon’s milestone timelines to visually show how quickly similar programs have progressed to key milestones such as IND applications, first patient dosing and key clinical readouts.
Optimize your ADC partnership strategy by identifying new companies as soon as they enter the field or release new data.
Use Beacon’s deals and companies data to search companies by categories like geography, most recent fundraising (Seed, Series A, Series B etc.) payloads being used on their pipeline and more. Dig deeper into this data with curated summaries of existing partnerships and deals these companies are part of.
Beacon ADC Database: The Numbers
Beacon ADC Database: Key Data Segments
Beacon ADC is a manually curated database of comprehensive, high quality, and accurate, preclinical and clinical drug, trial and commercial data, offering unrivalled insight into the ADC development landscape.
Drug Data
Revolutionize your landscape searching for ADC drugs.
Utilize >20 unique ADC search filters, to find programs based on niche technologies such as payload, linker, payload mechanism, target, disease indication & therapeutic class.
Trial Data
Optimize your ADC clinical trial design searching capabilities.
Seamlessly benchmark clinical trial results and search the ADC trial landscape based on drug technologies, combination trials, trial locations, trial phase, disease indication & many more.
Milestones
A unique ADC development milestone filter and visualization tool.
Track past, present, and future ADC drug development milestones, including drug and trial readouts, asset history and regulatory announcements.
Company Data
Your centralized location for ADC company intelligence.
Identify competitors and business development opportunities, using unique company filters including, company type, HQ locations, operating status & latest funding round, and technologies/diseases targeted in their pipeline.
Deal Data
De-risk your ADC partnership & fundraising projects.
Search ADC deals using custom search filters based on drug technologies involved, deal value & upfront payments, deal type to filter M&A, financing & partnership/licensing deals, geographic market, funding type & many more.
Beacon ADC Database: Drug Modalities
Analyze 3,300+ drugs (preclinical and clinical) and 3,800+ clinical trials (from early to late stage).
Beacon ADC covers antibody drug conjugates and related conjugate therapies including:
- ADC (Antibody-Drug Conjugates): Including Dual Payload ADCs and Bispecific ADCs
- Novel Format Conjugates: Including Antibody Oligonucleotide Conjugates & Degrader Antibody Conjugates
- Small Molecule Drug Conjugates
- Radioconjugates
- Peptide & Protein Drug Conjugates
- Immunotoxins
- Other conjugates including Small Molecule Drug-Conjugated Nanoparticles & Liposomal Drug Conjugates
Beacon ADC also includes a host of preclinical data including, cell line and animal model experimental data.
Who Is Beacon ADC Database For?
Beacon ADC is a manually curated database of comprehensive, high quality, and accurate, preclinical and clinical drug, trial and commercial data, offering unrivalled insight into the ADC development landscape.
Scientific Strategy Leader
Select the right pipeline for your ADC drug development
Research Scientist
Validate new targets & inform your ADC molecular design
Clinical Development
Design optimized ADC clinical trials & benchmark against the competition
Business Development
Uncover new ADC licensing, partnership and fundraising opportunities
Competitive Intelligence
Track competitive threats & emerging ADC technologies
Translational Development
Confidently take your preclinical ADC drug into the clinic
Related Resources
Check out ADC related resources available from Beacon
Our Experts

Yu-Shin Hsu
Lead Research Analyst

Jake Morris
Senior Account Manager

Eleni Taoula
Account Manager
Hanson Wade Events
Check out the upcoming events from Hanson Wade